BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10986007)

  • 1. Dose-response relationships for induction of CYP1A1 and CYP1A2 enzyme activity in liver, lung, and skin in female mice following subchronic exposure to polychlorinated biphenyls.
    DeVito MJ; Ménache MG; Diliberto JJ; Ross DG; Birnbaum LS
    Toxicol Appl Pharmacol; 2000 Sep; 167(3):157-72. PubMed ID: 10986007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative potency based on hepatic enzyme induction predicts immunosuppressive effects of a mixture of PCDDS/PCDFS and PCBS.
    Smialowicz RJ; DeVito MJ; Williams WC; Birnbaum LS
    Toxicol Appl Pharmacol; 2008 Mar; 227(3):477-84. PubMed ID: 18190939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,3',4,4',5-pentachlorobiphenyl (PCB 118) (Cas No. 31508-00-6) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Nov; (531):1-218. PubMed ID: 17342196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Aug; (530):1-258. PubMed ID: 17160104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTP technical report on the toxicology and carcinogenesis studies of 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (Gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 May; (529):4-168. PubMed ID: 16835634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicology and carcinogenesis studies of 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Sep; (525):1-198. PubMed ID: 17160103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response relationships for polyhalogenated dioxins and dibenzofurans following subchronic treatment in mice. I. CYP1A1 and CYP1A2 enzyme activity in liver, lung, and skin.
    DeVito MJ; Diliberto JJ; Ross DG; Menache MG; Birnbaum LS
    Toxicol Appl Pharmacol; 1997 Dec; 147(2):267-80. PubMed ID: 9439722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time- and concentration-dependent induction of CYP1A1 and CYP1A2 in precision-cut rat liver slices incubated in dynamic organ culture in the presence of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Drahushuk AT; McGarrigle BP; Slezak BP; Stegeman JJ; Olson JR
    Toxicol Appl Pharmacol; 1999 Mar; 155(2):127-38. PubMed ID: 10053167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative ability of various PCBs, PCDFs, and TCDD to induce cytochrome P450 1A1 and 1A2 activity following 4 weeks of treatment.
    De Vito MJ; Maier WE; Diliberto JJ; Birnbaum LS
    Fundam Appl Toxicol; 1993 Jan; 20(1):125-30. PubMed ID: 8432423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated dose-response analysis and comparative toxicogenomic evaluation of the hepatic effects elicited by TCDD, TCDF, and PCB126 in C57BL/6 mice.
    Kopec AK; Burgoon LD; Ibrahim-Aibo D; Burg AR; Lee AW; Tashiro C; Potter D; Sharratt B; Harkema JR; Rowlands JC; Budinsky RA; Zacharewski TR
    Toxicol Sci; 2010 Nov; 118(1):286-97. PubMed ID: 20702594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of TCDD and PCB CYP1A induction sensitivities in fresh hepatocytes from human donors, sprague-dawley rats, and rhesus monkeys and HepG2 cells.
    Silkworth JB; Koganti A; Illouz K; Possolo A; Zhao M; Hamilton SB
    Toxicol Sci; 2005 Oct; 87(2):508-19. PubMed ID: 16049271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of toxic equivalency factors for induction of cytochromes P450 CYP1A1 and CYP1A2 enzyme activity by dioxin-like compounds.
    Toyoshiba H; Walker NJ; Bailer AJ; Portier CJ
    Toxicol Appl Pharmacol; 2004 Jan; 194(2):156-68. PubMed ID: 14736496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-response relationships of tissue distribution and induction of CYP1A1 and CYP1A2 enzymatic activities following acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice.
    Diliberto JJ; Akubue PI; Luebke RW; Birnbaum LS
    Toxicol Appl Pharmacol; 1995 Feb; 130(2):197-208. PubMed ID: 7871533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of subchronic 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on immune system and target gene responses in mice: calculation of benchmark doses for CYP1A1 and CYP1A2 related enzyme activities.
    Vogel C; Donat S; Döhr O; Kremer J; Esser C; Roller M; Abel J
    Arch Toxicol; 1997; 71(6):372-82. PubMed ID: 9195019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential relative effect potencies of some dioxin-like compounds in human peripheral blood lymphocytes and murine splenic cells.
    van Ede KI; Gaisch KP; van den Berg M; van Duursen MB
    Toxicol Lett; 2014 Apr; 226(1):43-52. PubMed ID: 24472611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-response relationships in mice following subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: CYP1A1, CYP1A2, estrogen receptor, and protein tyrosine phosphorylation.
    DeVito MJ; Ma X; Babish JG; Menache M; Birnbaum LS
    Toxicol Appl Pharmacol; 1994 Jan; 124(1):82-90. PubMed ID: 8291065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of precision-cut liver slices in dynamic organ culture as an in vitro model for studying CYP1A1 and CYP1A2 induction.
    Drahushuk AT; McGarrigle BP; Tai HL; Kitareewan S; Goldstein JA; Olson JR
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):393-403. PubMed ID: 8887457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of relative potencies of PCB126 and PCB169 for the immunotoxicities in ovalbumin (OVA)-immunized mice.
    Pan X; Inouye K; Ito T; Nagai H; Takeuchi Y; Miyabara Y; Tohyama C; Nohara K
    Toxicology; 2004 Nov; 204(1):51-60. PubMed ID: 15369848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.